NCT00454558 - An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions

Hypertension, Pulmonary

Interventions

DRUG

Riociguat (Adempas, BAY63-2521)

Biweekly uptitration of BAY63-2521 (Oral sGC Stimulator) starting from 1.0 mg TID up to 2.5 mg TID in steps of +0.5 mg according to safety and tolerability.

Trial Locations (15)

12559

Berlin

17475

Greifswald

20246

Hamburg

30625

Hanover

35392

Giessen

50924

Cologne

61231

Bad Nauheim

66421

Homburg

69120

Heidelberg

74245

Löwenstein

81377

München

93042

Regensburg

01307

Dresden

04103

Leipzig

06120

Halle